OICR Official Calls for More Investment in Canadian Personalized Medicine | GenomeWeb

NEW YORK (GenomeWeb News) – Canada needs to invest in genomics research and personalized medicine in order to profit from advances in this area, according to an early release commentary article appearing online today in the Canadian Medical Association Journal.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.